From Ann Wills

 Guardian 9.9.20.  “OXFORD UNIVERSITY COVID VACCINE TRIAL PUT ON HOLD DUE TO POSSIBLE ADVERSE REACTION IN PARTICIPANT”

An Oxford University & AstraZeneca coronavirus vaccine trial has been halted to review the ‘potentially unexplained illness’ in one of the participants.  The participant who triggered a global shutdown of AstraZeneca’s Phase 3 Covid-19 vaccine trials was a woman in UK who experienced neurological symptoms consistent with a rare but serious spinal inflammatory disorder called transverse myelitis, the drug maker’s Chief Executive, Pascal Soriot said.